Revekka Papacharalambous
6 Iroon Avenue
Nicosia, 2371, Cyprus
Nicosia, 2371, Cyprus
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinicopathological and serological spectrum of idiopathic inflammatory myopathies: Experience from a neuromuscular referral center in Cyprus.
Journal: Journal of neuromuscular diseases
Published: August 18, 2026
Semaglutide Selectively Improves Metabolic and Cognitive Function in 5xFAD Mice.
Journal: International journal of molecular sciences
Published: April 28, 2026
Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1A.
Journal: Molecular therapy. Nucleic acids
Published: September 29, 2025
A dose escalation and safety study of AAVrh10-mediated Schwann cell-targeted gene therapy for CMT1X.
A dose escalation and safety study of AAVrh10-mediated Schwann cell-targeted gene therapy for CMT1X.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: September 08, 2024
Treatment of the CRND8 mouse model for cerebral amyloid angiopathy, exhibited increased levels of neuron specific enolase in brain tissue following long-term treatment with a modified C5a receptor agonist, accompanied by improved cognitive function.
Journal: Biochemical and biophysical research communications
Published: May 05, 2023
Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer's disease.
Journal: Frontiers in immunology
Published: May 18, 2022
C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer's disease.
Journal: PloS one
Published: July 12, 2019
A novel case of inclusion body myositis and myasthenia gravis.
Journal: Neuromuscular disorders : NMD
Published: June 13, 2019
Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy.
Journal: Frontiers in molecular neuroscience
Published: March 13, 2017
Genetic background modifies amyloidosis in a mouse model of ATTR neuropathy.
Journal: Biochemistry and biophysics reports
Published: May 01, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026